Tonix Pharmaceuticals Stock News

Full story available on Benzinga.com

An Investigator Initiated Phase 2 Clinical Trial of TNX-1900 In Patients with Binge Eating Disorder Planned for Second Half 2022

An Investigator Initiated Phase 2 Clinical Trial of TNX-1900 In Patients with Binge Eating Disorder Planned for Second Half 2022 Binge Eating Disorder is Estimated to Affect 2.8 Million American Adults1-3 Expands Uses of Tonix’s Proprietary Potentiated Oxytocin for Intranasal Administration to a Potential New Indication CHATHAM, N.J., March 07, 2022 (GLOBE NEWSWIRE) — Tonix … The post Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Evaluate TNX-1900 (Intranasal Potentiated Oxytocin) for Treating Binge Eating Disorder appeared first on ForexTV .

Buyers are unwinding their trades in a big way, following through on the profit-taking they initiated yesterday.

Buyers are unwinding their trades in a big way, following through on the profit-taking they initiated yesterday.

NEW YORK , March 4, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VEON, EJH, TNXP, AAL, and OCGN. … Full story available on Benzinga.com

Buyers are unwinding their trades in a big way, following through on the profit-taking they initiated yesterday.

The company wins orphan drug designation for one of its pipeline programs.

The company wins orphan drug designation for one of its pipeline programs.

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares are rallying higher Thursday after the company announced the FDA has granted Orphan-Drug Designation for TNX-2900 for the treatment of Prader-

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP ) shares are rallying higher Thursday after the company announced the FDA has granted Orphan-Drug Designation for TNX-2900 for the treatment of Prader-Willi syndrome. The co-exclusive license allows Tonix to expand its intranasal potentiated oxytocin development program to a new indication. Tonix Pharmaceuticals was up 37.31% at 26 cents Thursday afternoon. Tonix Pharmaceuticals Daily Chart Analysis The stock was able to cross resistance in what traders call a falling wedge pattern. This pattern can be seen by the falling highs and lows, with highs falling at a steeper rate than the lows. The falling wedge pattern is known to be a bullish reversal pattern if the stock can cross … Full story available on Benzinga.com

The company wins orphan drug designation for one of its pipeline programs.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Here''s the big news that''s driving shares of Tonix Pharmaceuticals'' TNXP stock more than 40% higher on a mixed day in the markets. The post Why Is Tonix Pharmaceuticals (TNXP) Stock Up Today? appeared first on InvestorPlace . More From InvestorPlace Get in Now on Tiny $3 ‘Forever Battery’ Stock It doesn’t matter if you have $500 in savings or $5 million. Do this now. Stock Prodigy Who Found NIO at $2… Says Buy THIS Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Gainers: Indonesia INDO +60%.Tonix Pharmaceutical TNXP +51%.Eos Energy Enterprises EOSE +33%.Rimini Street RMNI +30%.KLX Energy Services (KLXE) +18%.DBV Technologies…

What you need to know about trading penny stocks on March 3rd The post Trading Penny Stocks? Top Stock Market News for March 3rd, 2022 appeared first on Penny Stocks to Buy, Picks, News and Informatio